← Back to Search

Epidermal Micrografts

Micrografting for Skin Cancer

N/A
Waitlist Available
Led By Ashish C. Bhatia, MD
Research Sponsored by Momelan Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This case series will assess the use of suction blister epidermal grafts harvested by a novel device on select patients that have wounds from Mohs or excisional surgery.

Eligible Conditions
  • Skin Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Wound healing/scarring
Secondary outcome measures
Incidence of adverse events
Physician global satisfaction
Subject global satisfaction

Trial Design

1Treatment groups
Experimental Treatment
Group I: MicrograftingExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Momelan TechnologiesLead Sponsor
3 Previous Clinical Trials
18 Total Patients Enrolled
Ashish C. Bhatia, MDPrincipal InvestigatorDuPage Medical Group

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025